-
1
-
-
63549096634
-
Hereditary ovarian carcinoma: heterogeneity, molecular genetics, pathology, and management
-
Lynch HT, Casey MJ, Snyder CL, Bewtra C, Lynch JF, Butts M, et al. Hereditary ovarian carcinoma: heterogeneity, molecular genetics, pathology, and management. Mol Oncol. 2009;3:97-137
-
(2009)
Mol Oncol
, vol.3
, pp. 97-137
-
-
Lynch, H.T.1
Casey, M.J.2
Snyder, C.L.3
Bewtra, C.4
Lynch, J.F.5
Butts, M.6
-
2
-
-
36448996703
-
Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations
-
Fackenthal JD, Olopade OI. Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations. Nat Rev. 2007;7:937-48
-
(2007)
Nat Rev
, vol.7
, pp. 937-948
-
-
Fackenthal, J.D.1
Olopade, O.I.2
-
3
-
-
61349148781
-
Associations of high-grade prostate cancer with BRCA1 and BRCA2 founder mutations
-
Agalliu I, Gern R, Leanza S, Burk RD. Associations of high-grade prostate cancer with BRCA1 and BRCA2 founder mutations. Clin Cancer Res. 2009;15:1112-20
-
(2009)
Clin Cancer Res
, vol.15
, pp. 1112-1120
-
-
Agalliu, I.1
Gern, R.2
Leanza, S.3
Burk, R.D.4
-
4
-
-
25144445294
-
BRCA1 and BRCA2 pathways and the risk of cancers other than breast or ovarian
-
Friedenson B. BRCA1 and BRCA2 pathways and the risk of cancers other than breast or ovarian. MedGenMed. 2005;7:60
-
(2005)
MedGenMed
, vol.7
, pp. 60
-
-
Friedenson, B.1
-
5
-
-
10944255106
-
Risk of cancer at sites other than the breast in Swedish families eligible for BRCA1 or BRCA2 mutation testing
-
Lorenzo Bermejo J, Hemminki K. Risk of cancer at sites other than the breast in Swedish families eligible for BRCA1 or BRCA2 mutation testing. Ann Oncol. 2004;15:1834-41
-
(2004)
Ann Oncol
, vol.15
, pp. 1834-1841
-
-
Lorenzo Bermejo, J.1
Hemminki, K.2
-
6
-
-
84864360055
-
Risk of cancer other than breast or ovarian in individuals with BRCA1 and BRCA2 mutations
-
Moran A, O'Hara C, Khan S, Shack L, Woodward E, Maher ER, et al. Risk of cancer other than breast or ovarian in individuals with BRCA1 and BRCA2 mutations. Fam Cancer. 2012;11:235-42
-
(2012)
Fam Cancer
, vol.11
, pp. 235-242
-
-
Moran, A.1
O'Hara, C.2
Khan, S.3
Shack, L.4
Woodward, E.5
Maher, E.R.6
-
7
-
-
64749086562
-
The prevalence of BRCA1 mutations among young women with triple-negative breast cancer
-
Young SR, Pilarski RT, Donenberg T, Shapiro C, Hammond LS, Miller J, et al. The prevalence of BRCA1 mutations among young women with triple-negative breast cancer. BMC Cancer. 2009;9:86
-
(2009)
BMC Cancer
, vol.9
, pp. 86
-
-
Young, S.R.1
Pilarski, R.T.2
Donenberg, T.3
Shapiro, C.4
Hammond, L.S.5
Miller, J.6
-
8
-
-
44849130662
-
The prevalence of BRCA1 and BRCA2 germline mutations in high-risk breast cancer patients of Chinese Han nationality: two recurrent mutations were identified
-
Li WF, Hu Z, Rao NY, Song CG, Zhang B, Cao MZ, et al. The prevalence of BRCA1 and BRCA2 germline mutations in high-risk breast cancer patients of Chinese Han nationality: two recurrent mutations were identified. Breast Cancer Res Treat. 2008;110:99-109
-
(2008)
Breast Cancer Res Treat
, vol.110
, pp. 99-109
-
-
Li, W.F.1
Hu, Z.2
Rao, N.Y.3
Song, C.G.4
Zhang, B.5
Cao, M.Z.6
-
9
-
-
33749022506
-
Basal-like breast cancer and the BRCA1 phenotype
-
Turner NC, Reis-Filho JS. Basal-like breast cancer and the BRCA1 phenotype. Oncogene. 2006;25:5846-53
-
(2006)
Oncogene
, vol.25
, pp. 5846-5853
-
-
Turner, N.C.1
Reis-Filho, J.S.2
-
10
-
-
84890247728
-
Risk of having BRCA1 mutation in high-risk women with triple-negative breast cancer: a meta-analysis
-
Tun NM, Villani G, Ong K, Yoe L, Bo ZM. Risk of having BRCA1 mutation in high-risk women with triple-negative breast cancer: a meta-analysis. Clin Genet. 2014;85:43-8
-
(2014)
Clin Genet
, vol.85
, pp. 43-48
-
-
Tun, N.M.1
Villani, G.2
Ong, K.3
Yoe, L.4
Bo, Z.M.5
-
11
-
-
84896995635
-
Two decades after BRCA: setting paradigms in personalized cancer care and prevention
-
Couch FJ, Nathanson KL, Offit K. Two decades after BRCA: setting paradigms in personalized cancer care and prevention. Science. 2014;343:1466-70
-
(2014)
Science
, vol.343
, pp. 1466-1470
-
-
Couch, F.J.1
Nathanson, K.L.2
Offit, K.3
-
12
-
-
77956611159
-
Variation in breast cancer subtypes with age and race/ethnicity
-
Parise CA, Bauer KR, Caggiano V. Variation in breast cancer subtypes with age and race/ethnicity. Crit Rev Oncol Hematol. 2010;76:44-52
-
(2010)
Crit Rev Oncol Hematol
, vol.76
, pp. 44-52
-
-
Parise, C.A.1
Bauer, K.R.2
Caggiano, V.3
-
13
-
-
34547860028
-
Differences in breast carcinoma characteristics in newly diagnosed African-American and Caucasian patients: a single-institution compilation compared with the National Cancer Institute's Surveillance, Epidemiology, and End Results database
-
Morris GJ, Naidu S, Topham AK, Guiles F, Xu Y, McCue P, et al. Differences in breast carcinoma characteristics in newly diagnosed African-American and Caucasian patients: a single-institution compilation compared with the National Cancer Institute's Surveillance, Epidemiology, and End Results database. Cancer. 2007;110:876-84
-
(2007)
Cancer
, vol.110
, pp. 876-884
-
-
Morris, G.J.1
Naidu, S.2
Topham, A.K.3
Guiles, F.4
Xu, Y.5
McCue, P.6
-
14
-
-
68149163711
-
Triple-negative breast cancers are increased in black women regardless of age or body mass index
-
Stead LA, Lash TL, Sobieraj JE, Chi DD, Westrup JL, Charlot M, et al. Triple-negative breast cancers are increased in black women regardless of age or body mass index. Breast Cancer Res. 2009;11:R18
-
(2009)
Breast Cancer Res
, vol.11
, pp. R18
-
-
Stead, L.A.1
Lash, T.L.2
Sobieraj, J.E.3
Chi, D.D.4
Westrup, J.L.5
Charlot, M.6
-
15
-
-
0037434090
-
Differences in breast cancer stage, treatment, and survival by race and ethnicity
-
Li CI, Malone KE, Daling JR. Differences in breast cancer stage, treatment, and survival by race and ethnicity. Arch Intern Med. 2003;163:49-56
-
(2003)
Arch Intern Med
, vol.163
, pp. 49-56
-
-
Li, C.I.1
Malone, K.E.2
Daling, J.R.3
-
16
-
-
80051518997
-
Triple-negative breast cancer in Hispanic patients: high prevalence, poor prognosis, and association with menopausal status, body mass index, and parity
-
Lara-Medina F, Perez-Sanchez V, Saavedra-Perez D, Blake-Cerda M, Arce C, Motola-Kuba D, et al. Triple-negative breast cancer in Hispanic patients: high prevalence, poor prognosis, and association with menopausal status, body mass index, and parity. Cancer. 2011;117:3658-69
-
(2011)
Cancer
, vol.117
, pp. 3658-3669
-
-
Lara-Medina, F.1
Perez-Sanchez, V.2
Saavedra-Perez, D.3
Blake-Cerda, M.4
Arce, C.5
Motola-Kuba, D.6
-
17
-
-
65649112508
-
BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast-ovarian cancer
-
Hall MJ, Reid JE, Burbidge LA, Pruss D, Deffenbaugh AM, Frye C, et al. BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast-ovarian cancer. Cancer. 2009;115:2222-33
-
(2009)
Cancer
, vol.115
, pp. 2222-2233
-
-
Hall, M.J.1
Reid, J.E.2
Burbidge, L.A.3
Pruss, D.4
Deffenbaugh, A.M.5
Frye, C.6
-
18
-
-
66649102437
-
Performance of prediction models for BRCA mutation carriage in three racial/ethnic groups: findings from the Northern California Breast Cancer Family Registry
-
Kurian AW, Gong GD, John EM, Miron A, Felberg A, Phipps AI, et al. Performance of prediction models for BRCA mutation carriage in three racial/ethnic groups: findings from the Northern California Breast Cancer Family Registry. Cancer Epidemiol Biomarkers Prev. 2009;18:1084-91
-
(2009)
Cancer Epidemiol Biomarkers Prev
, vol.18
, pp. 1084-1091
-
-
Kurian, A.W.1
Gong, G.D.2
John, E.M.3
Miron, A.4
Felberg, A.5
Phipps, A.I.6
-
19
-
-
84865356805
-
Identification of the prevalent BRCA1 and BRCA2 mutations in the female population of Puerto Rico
-
Dutil J, Colon-Colon JL, Matta JL, Sutphen R, Echenique M. Identification of the prevalent BRCA1 and BRCA2 mutations in the female population of Puerto Rico. Cancer Genet. 2012;205:242-8
-
(2012)
Cancer Genet
, vol.205
, pp. 242-248
-
-
Dutil, J.1
Colon-Colon, J.L.2
Matta, J.L.3
Sutphen, R.4
Echenique, M.5
-
20
-
-
34548076029
-
Evidence for common ancestral origin of a recurring BRCA1 genomic rearrangement identified in high-risk Hispanic families
-
Weitzel JN, Lagos VI, Herzog JS, Judkins T, Hendrickson B, Ho JS, et al. Evidence for common ancestral origin of a recurring BRCA1 genomic rearrangement identified in high-risk Hispanic families. Cancer Epidemiology Biomarkers Prev. 2007;16:1615-20
-
(2007)
Cancer Epidemiology Biomarkers Prev
, vol.16
, pp. 1615-1620
-
-
Weitzel, J.N.1
Lagos, V.I.2
Herzog, J.S.3
Judkins, T.4
Hendrickson, B.5
Ho, J.S.6
-
21
-
-
55949092708
-
High sensitivity of BRCA1-deficient mammary tumors to the PARP inhibitor AZD2281 alone and in combination with platinum drugs
-
Rottenberg S, Jaspers JE, Kersbergen A, van der Burg E, Nygren AO, Zander SA, et al. High sensitivity of BRCA1-deficient mammary tumors to the PARP inhibitor AZD2281 alone and in combination with platinum drugs. Proc Natl Acad Sci U S A. 2008;105:17079-84
-
(2008)
Proc Natl Acad Sci U S A
, vol.105
, pp. 17079-17084
-
-
Rottenberg, S.1
Jaspers, J.E.2
Kersbergen, A.3
van der Burg, E.4
Nygren, A.O.5
Zander, S.A.6
-
23
-
-
67650471685
-
Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers
-
Fong PC, Boss DS, Yap TA, Tutt A, Wu P, Mergui-Roelvink M, et al. Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers. N Engl J Med. 2009;361:123-34
-
(2009)
N Engl J Med
, vol.361
, pp. 123-134
-
-
Fong, P.C.1
Boss, D.S.2
Yap, T.A.3
Tutt, A.4
Wu, P.5
Mergui-Roelvink, M.6
-
24
-
-
77954032829
-
Poly(ADP)-ribose polymerase inhibition: frequent durable responses in BRCA carrier ovarian cancer correlating with platinum-free interval
-
Fong PC, Yap TA, Boss DS, Carden CP, Mergui-Roelvink M, Gourley C, et al. Poly(ADP)-ribose polymerase inhibition: frequent durable responses in BRCA carrier ovarian cancer correlating with platinum-free interval. J Clin Oncol. 2010;28:2512-9
-
(2010)
J Clin Oncol
, vol.28
, pp. 2512-2519
-
-
Fong, P.C.1
Yap, T.A.2
Boss, D.S.3
Carden, C.P.4
Mergui-Roelvink, M.5
Gourley, C.6
-
25
-
-
77955019276
-
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial
-
Tutt A, Robson M, Garber JE, Domchek SM, Audeh MW, Weitzel JN, et al. Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial. Lancet. 2010;376:235-44
-
(2010)
Lancet
, vol.376
, pp. 235-244
-
-
Tutt, A.1
Robson, M.2
Garber, J.E.3
Domchek, S.M.4
Audeh, M.W.5
Weitzel, J.N.6
-
26
-
-
77955039099
-
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial
-
Audeh MW, Carmichael J, Penson RT, Friedlander M, Powell B, Bell-McGuinn KM, et al. Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial. Lancet. 2010;376:245-51
-
(2010)
Lancet
, vol.376
, pp. 245-251
-
-
Audeh, M.W.1
Carmichael, J.2
Penson, R.T.3
Friedlander, M.4
Powell, B.5
Bell-McGuinn, K.M.6
-
27
-
-
84880777712
-
The poly(ADP-ribose) polymerase inhibitor niraparib (MK4827) in BRCA mutation carriers and patients with sporadic cancer: a phase 1 dose-escalation trial
-
Sandhu SK, Schelman WR, Wilding G, Moreno V, Baird RD, Miranda S, et al. The poly(ADP-ribose) polymerase inhibitor niraparib (MK4827) in BRCA mutation carriers and patients with sporadic cancer: a phase 1 dose-escalation trial. Lancet Oncol. 2013;14:882-92
-
(2013)
Lancet Oncol
, vol.14
, pp. 882-892
-
-
Sandhu, S.K.1
Schelman, W.R.2
Wilding, G.3
Moreno, V.4
Baird, R.D.5
Miranda, S.6
-
28
-
-
34249717959
-
Diagnostic accuracy of methods for the detection of BRCA1 and BRCA2 mutations: a systematic review
-
Gerhardus A, Schleberger H, Schlegelberger B, Gadzicki D. Diagnostic accuracy of methods for the detection of BRCA1 and BRCA2 mutations: a systematic review. Eur J Hum Genet. 2007;15:619-27
-
(2007)
Eur J Hum Genet
, vol.15
, pp. 619-627
-
-
Gerhardus, A.1
Schleberger, H.2
Schlegelberger, B.3
Gadzicki, D.4
-
29
-
-
79951805438
-
Massive parallel amplicon sequencing of the breast cancer genes BRCA1 and BRCA2: opportunities, challenges, and limitations
-
De Leeneer K, Hellemans J, De Schrijver J, Baetens M, Poppe B, Van Criekinge W, et al. Massive parallel amplicon sequencing of the breast cancer genes BRCA1 and BRCA2: opportunities, challenges, and limitations. Hum Mutat. 2011;32:335-44
-
(2011)
Hum Mutat
, vol.32
, pp. 335-344
-
-
De Leeneer, K.1
Hellemans, J.2
De Schrijver, J.3
Baetens, M.4
Poppe, B.5
Van Criekinge, W.6
-
30
-
-
77955059918
-
Genetic diagnosis of familial breast cancer using clonal sequencing
-
Morgan JE, Carr IM, Sheridan E, Chu CE, Hayward B, Camm N, et al. Genetic diagnosis of familial breast cancer using clonal sequencing. Hum Mutat. 2010;31:484-91
-
(2010)
Hum Mutat
, vol.31
, pp. 484-491
-
-
Morgan, J.E.1
Carr, I.M.2
Sheridan, E.3
Chu, C.E.4
Hayward, B.5
Camm, N.6
-
31
-
-
84865070623
-
Long-range PCR and next-generation sequencing of BRCA1 and BRCA2 in breast cancer
-
Ozcelik H, Shi X, Chang MC, Tram E, Vlasschaert M, Di Nicola N, et al. Long-range PCR and next-generation sequencing of BRCA1 and BRCA2 in breast cancer. J Mol Diagn. 2012;14:467-75
-
(2012)
J Mol Diagn
, vol.14
, pp. 467-475
-
-
Ozcelik, H.1
Shi, X.2
Chang, M.C.3
Tram, E.4
Vlasschaert, M.5
Di Nicola, N.6
-
32
-
-
81055126264
-
Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing
-
Walsh T, Casadei S, Lee MK, Pennil CC, Nord AS, Thornton AM, et al. Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing. Proc Natl Acad Sci U S A. 2011;108:18032-7
-
(2011)
Proc Natl Acad Sci U S A
, vol.108
, pp. 18032-18037
-
-
Walsh, T.1
Casadei, S.2
Lee, M.K.3
Pennil, C.C.4
Nord, A.S.5
Thornton, A.M.6
-
33
-
-
84875519657
-
Nonoptical massive parallel DNA sequencing of BRCA1 and BRCA2 genes in a diagnostic setting
-
Costa JL, Sousa S, Justino A, Kay T, Fernandes S, Cirnes L, et al. Nonoptical massive parallel DNA sequencing of BRCA1 and BRCA2 genes in a diagnostic setting. Hum Mutat. 2013;34:629-35
-
(2013)
Hum Mutat
, vol.34
, pp. 629-635
-
-
Costa, J.L.1
Sousa, S.2
Justino, A.3
Kay, T.4
Fernandes, S.5
Cirnes, L.6
-
34
-
-
85006185413
-
-
Accessed 13 August
-
LOVD BRCA database. http://brca.iarc.fr/LOVD. Accessed 13 August 2015
-
(2015)
-
-
-
35
-
-
78650372104
-
Prevalence of BRCA1 and BRCA2 mutations in women with breast carcinoma In Situ and referred for genetic testing
-
HallMJ, Reid JE, Wenstrup RJ. Prevalence of BRCA1 and BRCA2 mutations in women with breast carcinoma In Situ and referred for genetic testing. Cancer Prev Res. 2010;3:1579-85
-
(2010)
Cancer Prev Res
, vol.3
, pp. 1579-1585
-
-
Hall, M.J.1
Reid, J.E.2
Wenstrup, R.J.3
-
37
-
-
85006209110
-
-
Accessed 13 August
-
1000 genomes website. http://www.1000genomes.org. Accessed 13 August 2015
-
(2015)
-
-
-
38
-
-
84948568072
-
-
Accessed 13 August
-
Breast Cancer Information Core. http://research.nhgri.nih.gov/projects/bic. Accessed 13 August 2015
-
(2015)
Breast Cancer Information Core
-
-
-
39
-
-
85006213484
-
-
Accessed 13 August
-
Align-GVGD website. http://agvgd.iarc.fr. Accessed 13 August 2015
-
(2015)
-
-
-
40
-
-
79953755778
-
A molecular phylogeny of living primates
-
Perelman P, Johnson WE, Roos C, Seuanez HN, Horvath JE, Moreira MA, et al. A molecular phylogeny of living primates. PLoS Genet. 2011;7:e1001342
-
(2011)
PLoS Genet
, vol.7
-
-
Perelman, P.1
Johnson, W.E.2
Roos, C.3
Seuanez, H.N.4
Horvath, J.E.5
Moreira, M.A.6
-
41
-
-
84884900317
-
The new sequencer on the block: comparison of Life Technology's Proton sequencer to an Illumina HiSeq for whole-exome sequencing
-
Boland JF, Chung CC, Roberson D, Mitchell J, Zhang X, Im KM, et al. The new sequencer on the block: comparison of Life Technology's Proton sequencer to an Illumina HiSeq for whole-exome sequencing. Hum Genet. 2013;132:1153-63
-
(2013)
Hum Genet
, vol.132
, pp. 1153-1163
-
-
Boland, J.F.1
Chung, C.C.2
Roberson, D.3
Mitchell, J.4
Zhang, X.5
Im, K.M.6
-
42
-
-
16444381731
-
Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer
-
Armstrong K, Micco E, Carney A, Stopfer J, Putt M. Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer. JAMA. 2005;293:1729-36
-
(2005)
JAMA
, vol.293
, pp. 1729-1736
-
-
Armstrong, K.1
Micco, E.2
Carney, A.3
Stopfer, J.4
Putt, M.5
-
43
-
-
77956518820
-
Influence of race/ethnicity on genetic counseling and testing for hereditary breast and ovarian cancer
-
Forman AD, Hall MJ. Influence of race/ethnicity on genetic counseling and testing for hereditary breast and ovarian cancer. Breast J. 2009;15 Suppl 1:S56-62
-
(2009)
Breast J
, vol.15
, pp. S56-62
-
-
Forman, A.D.1
Hall, M.J.2
-
44
-
-
79955009383
-
Underutilization of BRCA1/2 testing to guide breast cancer treatment: black and Hispanic women particularly at risk
-
Levy DE, Byfield SD, Comstock CB, Garber JE, Syngal S, Crown WH, et al. Underutilization of BRCA1/2 testing to guide breast cancer treatment: black and Hispanic women particularly at risk. Genet Med. 2011;13:349-55
-
(2011)
Genet Med
, vol.13
, pp. 349-355
-
-
Levy, D.E.1
Byfield, S.D.2
Comstock, C.B.3
Garber, J.E.4
Syngal, S.5
Crown, W.H.6
-
45
-
-
85006204135
-
-
GetColor [https://getcolor.com]
-
-
-
-
46
-
-
84872579612
-
Prevalence and type of BRCA mutations in Hispanics undergoing genetic cancer risk assessment in the southwestern United States: a report from the Clinical Cancer Genetics Community Research Network
-
Weitzel JN, Clague J, Martir-Negron A, Ogaz R, Herzog J, Ricker C, et al. Prevalence and type of BRCA mutations in Hispanics undergoing genetic cancer risk assessment in the southwestern United States: a report from the Clinical Cancer Genetics Community Research Network. J Clin Oncol. 2013;31:210-6
-
(2013)
J Clin Oncol
, vol.31
, pp. 210-216
-
-
Weitzel, J.N.1
Clague, J.2
Martir-Negron, A.3
Ogaz, R.4
Herzog, J.5
Ricker, C.6
-
47
-
-
84922628243
-
Next-Generation Sequencing of the BRCA1 and BRCA2 Genes for the Genetic Diagnostics of Hereditary Breast and/or Ovarian Cancer
-
Trujillano D, Weiss ME, Schneider J, Koster J, Papachristos EB, Saviouk V, et al. Next-Generation Sequencing of the BRCA1 and BRCA2 Genes for the Genetic Diagnostics of Hereditary Breast and/or Ovarian Cancer. J Mol Diagn. 2015;17:162-70
-
(2015)
J Mol Diagn
, vol.17
, pp. 162-170
-
-
Trujillano, D.1
Weiss, M.E.2
Schneider, J.3
Koster, J.4
Papachristos, E.B.5
Saviouk, V.6
-
48
-
-
84907206454
-
Population-based screening for breast and ovarian cancer risk due to BRCA1 and BRCA2
-
Gabai-Kapara E, Lahad A, Kaufman B, Friedman E, Segev S, Renbaum P, et al. Population-based screening for breast and ovarian cancer risk due to BRCA1 and BRCA2. Proc Natl Acad Sci U S A. 2014;111:14205-10
-
(2014)
Proc Natl Acad Sci U S A
, vol.111
, pp. 14205-14210
-
-
Gabai-Kapara, E.1
Lahad, A.2
Kaufman, B.3
Friedman, E.4
Segev, S.5
Renbaum, P.6
-
49
-
-
85006221298
-
-
Accessed 13 August
-
Ion Ampliseq Designer website. http://www.ampliseq.com. Accessed 13 August 2015
-
(2015)
-
-
-
50
-
-
85006221878
-
-
Accessed 13 August
-
TMAP-torrent mapping alignment program GitHub page. http://github.com/iontorrent/TS/tree/master/Analysis/TMAP. Accessed 13 August 2015
-
(2015)
-
-
-
51
-
-
85006220206
-
-
Accessed 13 August
-
GLU: Genotype Library and Utilities google code papge. http://code.google.com/p/glu-genetics. Accessed 13 August 2015
-
(2015)
-
-
-
52
-
-
84875634162
-
Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration
-
Thorvaldsdottir H, Robinson JT, Mesirov JP. Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration. Brief Bioinform. 2013;14:178-92
-
(2013)
Brief Bioinform
, vol.14
, pp. 178-192
-
-
Thorvaldsdottir, H.1
Robinson, J.T.2
Mesirov, J.P.3
-
53
-
-
85006186325
-
-
Accessed 13 August
-
ClinVar website. http://www.ncbi.nlm.nih.gov/clinvar. Accessed 13 August 2015
-
(2015)
-
-
-
54
-
-
33644537810
-
Comprehensive statistical study of 452 BRCA1 missense substitutions with classification of eight recurrent substitutions as neutral
-
Tavtigian SV, Deffenbaugh AM, Yin L, Judkins T, Scholl T, Samollow PB, et al. Comprehensive statistical study of 452 BRCA1 missense substitutions with classification of eight recurrent substitutions as neutral. J Med Genet. 2006;43:295-305
-
(2006)
J Med Genet
, vol.43
, pp. 295-305
-
-
Tavtigian, S.V.1
Deffenbaugh, A.M.2
Yin, L.3
Judkins, T.4
Scholl, T.5
Samollow, P.B.6
-
55
-
-
33644993216
-
Computational approaches for predicting the biological effect of p53 missense mutations: a comparison of three sequence analysis based methods
-
Mathe E, Olivier M, Kato S, Ishioka C, Hainaut P, Tavtigian SV. Computational approaches for predicting the biological effect of p53 missense mutations: a comparison of three sequence analysis based methods. Nucleic Acids Res.2006;34:1317-25
-
(2006)
Nucleic Acids Res
, vol.34
, pp. 1317-1325
-
-
Mathe, E.1
Olivier, M.2
Kato, S.3
Ishioka, C.4
Hainaut, P.5
Tavtigian, S.V.6
-
56
-
-
84979529739
-
Supporting data for "Addressing health disparities in Hispanic breast cancer: Accurate and inexpensive sequencing of BRCA1 and BRCA2"
-
Dean M, Boland J, Yeager M, Im KM, Garland L, Rodriguez-Herrera M, et al. Supporting data for "Addressing health disparities in Hispanic breast cancer: Accurate and inexpensive sequencing of BRCA1 and BRCA2". GigaScience Database. 2015. http://dx.doi.org/10.5524/100154
-
(2015)
GigaScience Database
-
-
Dean, M.1
Boland, J.2
Yeager, M.3
Im, K.M.4
Garland, L.5
Rodriguez-Herrera, M.6
-
57
-
-
84896548016
-
Streamlined ion torrent PGM-based diagnostics: BRCA1 and BRCA2 genes as a model
-
Tarabeux J, Zeitouni B, Moncoutier V, Tenreiro H, Abidallah K, Lair S, et al: Streamlined ion torrent PGM-based diagnostics: BRCA1 and BRCA2 genes as a model. European journal of human genetics: EJHG 2014;22:535-41
-
(2014)
European journal of human genetics: EJHG
, vol.22
, pp. 535-541
-
-
Tarabeux, J.1
Zeitouni, B.2
Moncoutier, V.3
Tenreiro, H.4
Abidallah, K.5
Lair, S.6
-
58
-
-
84937758180
-
Validation of an NGS Approach for Diagnostic BRCA1/BRCA2 Mutation Testing
-
Dacheva D, Dodova R, Popov I, Goranova T, Mitkova A, Mitev V, et al. Validation of an NGS Approach for Diagnostic BRCA1/BRCA2 Mutation Testing. Molecular diagnosis & therapy 2015;19:119-30
-
(2015)
Molecular diagnosis & therapy
, vol.19
, pp. 119-130
-
-
Dacheva, D.1
Dodova, R.2
Popov, I.3
Goranova, T.4
Mitkova, A.5
Mitev, V.6
-
59
-
-
84976430922
-
New recurrent BRCA1/2 mutations in Polish patients with familial breast/ovarian cancer detected by next generation sequencing
-
Kluska A, Balabas A, Paziewska A, Kulecka M, Nowakowska D, Mikula M, et al. New recurrent BRCA1/2 mutations in Polish patients with familial breast/ovarian cancer detected by next generation sequencing. BMC medical genomics 2015;8:19
-
(2015)
BMC medical genomics
, vol.8
, pp. 19
-
-
Kluska, A.1
Balabas, A.2
Paziewska, A.3
Kulecka, M.4
Nowakowska, D.5
Mikula, M.6
-
60
-
-
84903459577
-
Evaluation and optimisation of indel detection workflows for ion torrent sequencing of the BRCA1 and BRCA2 genes
-
Yeo ZX, Wong JC, Rozen SG, Lee AS: Evaluation and optimisation of indel detection workflows for ion torrent sequencing of the BRCA1 and BRCA2 genes. BMC genomics 2014;15:516
-
(2014)
BMC genomics
, vol.15
, pp. 516
-
-
Yeo, Z.X.1
Wong, J.C.2
Rozen, S.G.3
Lee, A.S.4
-
61
-
-
84867400465
-
Development of a nextgeneration sequencing method for BRCA mutation screening: a comparison between a high-throughput and a benchtop platform
-
Chan M, Ji SM, Yeo ZX, Gan L, Yap E, Yap YS, et al. Development of a nextgeneration sequencing method for BRCA mutation screening: a comparison between a high-throughput and a benchtop platform. The Journal of molecular diagnostics: JMD 2012;14:602-12
-
(2012)
The Journal of molecular diagnostics: JMD
, vol.14
, pp. 602-612
-
-
Chan, M.1
Ji, S.M.2
Yeo, Z.X.3
Gan, L.4
Yap, E.5
Yap, Y.S.6
-
62
-
-
84886085839
-
A clinically validated diagnostic second-generation sequencing assay for detection of hereditary BRCA1 and BRCA2 mutations
-
Bosdet IE, Docking TR, Butterfield YS, Mungall AJ, Zeng T, Coope RJ, et al. A clinically validated diagnostic second-generation sequencing assay for detection of hereditary BRCA1 and BRCA2 mutations. The Journal of molecular diagnostics: JMD 2013;15:796-809
-
(2013)
The Journal of molecular diagnostics: JMD
, vol.15
, pp. 796-809
-
-
Bosdet, I.E.1
Docking, T.R.2
Butterfield, Y.S.3
Mungall, A.J.4
Zeng, T.5
Coope, R.J.6
|